ProPhase Labs Inc (PRPH)

Currency in USD
0.166
-0.009(-5.14%)
Closed·
0.1660.000(-0.12%)
·

PRPH Comments

What was this garbage
patience
PRPH is a LT Investment as it prepares to go forward with aggressive process and marketing...I see possibilities of $3. before July after a prediction by their legal team of 50 mil. in collection's. Do your due diligence and invest wisely..
Future collection of covod 19 test funds look very promising according to law firm involved by June July time frame. Mayo Clinic interest and involvement into esophageal test product is also encouraging.
Holding for future collections of funds that are expected
ProPhase's marketing strategies are already showing promise, as the company looks to integrate its capabilities with extensive physician networks for DTC prescription drugs. The anticipated launch of Equivir, an antiviral product, is also on the horizon, targeting the next year's cold and flu season.
As expected when good news arrives shorts cover bringing price down. Company is going in right direction, with solid plans and financial stability. Read or listen to 2/25 news and conference statements. The new COO has a good reputation for turn-arounds and pipeline to do so...jmo
lots of shorts leaving
Read latest news report
Analysis rating above is a strong buy, I think on their belief that their Financials looks strong for the future through the collection process and product development going forward. Tomorrow conference will give a summary.
Investors are holding strong as the company is looking forward to liquidity, and production. Especially in a down market...I am bullish and feel the price will be supported higher based on positive news . If .60c is supported I say 1$ + is possible looking forward to a positive meeting on Feb 25th
Looks like they are financially stabilized going forward, and have a good stradigy for collections in accounts receivables. Also a good product with a good marketing and sales strategy. looking forward to a higher price level support soon to 1-2$ range
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.